title: Characterization of a lipopolysaccharide-targeted monoclonal antibody and its variable fragments as candidates for prophylaxis against the obligate intracellular bacterial pathogen Coxiella burnetii.
abstract: Our previous study demonstrated that treatment of Coxiella burnetii with the phase I lipopolysaccharide (PI-LPS)-targeted monoclonal antibody (MAb) 1E4 significantly inhibited C. burnetii infection in mice, suggesting that 1E4 is a protective MAb. To determine whether passive transfer of antibodies (Abs) can provide protection against C. burnetii natural infection, we examined if passive transfer of 1E4 would protect SCID mice against C. burnetii aerosol infection. The results indicated that 1E4 conferred significant protection against aerosolized C. burnetii, suggesting that 1E4 may be useful for preventing C. burnetii natural infection. To further understand the mechanisms of 1E4-mediated protection and to test the possibility of using humanized 1E4 to prevent C. burnetii infection, we examined whether the Fab fragment of 1E4 (Fab1E4), a recombinant murine single-chain variable fragment (muscFv1E4), and a humanized single-chain variable fragment (huscFv1E4) retained the ability of 1E4 to inhibit C. burnetii infection. The results indicated that Fab1E4, muscFv1E4, and huscFv1E4 were able to inhibit C. burnetii infection in mice but that their ability to inhibit C. burnetii infection was lower than that of 1E4. In addition, treatment of C. burnetii with Fab1E4, muscFv1E4, or huscFv1E4 can block C. burnetii infection of macrophages. Interestingly, treatment of C. burnetii with huscFv1E4 can significantly reduce C. burnetii infectivity in human macrophages. This report provides the first evidence to demonstrate that the humanized variable fragments of an LPS-specific MAb can neutralize C. burnetii infection and appears to be a promising step toward the potential use of a humanized MAb as emergency prophylaxis against C. burnetii exposure.
authors.affiliation: Department of Veterinary Pathobiology, College of Veterinary Medicine, University of Missouri-Columbia, Columbia, Missouri, USA.
authors.forename: Ying
authors.initials: Y
authors.lastname: Peng
authors.affiliation: Department of Veterinary Pathobiology, College of Veterinary Medicine, University of Missouri-Columbia, Columbia, Missouri, USA.
authors.forename: Laura
authors.initials: L
authors.lastname: Schoenlaub
authors.affiliation: Department of Veterinary Pathobiology, College of Veterinary Medicine, University of Missouri-Columbia, Columbia, Missouri, USA.
authors.forename: Alexandra
authors.initials: A
authors.lastname: Elliott
authors.affiliation: Department of Veterinary Pathobiology, College of Veterinary Medicine, University of Missouri-Columbia, Columbia, Missouri, USA.
authors.forename: William J
authors.initials: WJ
authors.lastname: Mitchell
authors.affiliation: Department of Veterinary Pathobiology, College of Veterinary Medicine, University of Missouri-Columbia, Columbia, Missouri, USA zhangguo@missouri.edu.
authors.forename: Guoquan
authors.initials: G
authors.lastname: Zhang
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology*; D016997:Coxiella burnetii / Q000276:immunology*; D005260:Female; D006801:Humans; D007116:Immunization, Passive; D008070:Lipopolysaccharides / Q000276:immunology*; D051379:Mice; D008807:Mice, Inbred BALB C; D016513:Mice, SCID; D008969:Molecular Sequence Data; D011778:Q Fever / Q000276:immunology / Q000517:prevention & control*; D057127:Single-Chain Antibodies / Q000276:immunology*
chemical_list: D000911:Antibodies, Monoclonal; D008070:Lipopolysaccharides; D057127:Single-Chain Antibodies
references.citation: J Med Microbiol. 2011 Jan;60(Pt 1):9-21
references.pmid: 21030501
references.citation: J Immunol. 1976 Sep;117(3):996-1003
references.pmid: 986414
references.citation: J Immunol. 2007 Dec 15;179(12):8372-80
references.pmid: 18056383
references.citation: Neth J Med. 2010 Dec;68(12):382-7
references.pmid: 21209463
references.citation: Acta Virol. 1975 Sep;19(5):426-31
references.pmid: 241247
references.citation: Methods Mol Biol. 2008;431:189-200
references.pmid: 18287757
references.citation: Ann N Y Acad Sci. 2003 Jun;990:510-20
references.pmid: 12860683
references.citation: J Immunol. 2004 Mar 15;172(6):3695-703
references.pmid: 15004173
references.citation: J Clin Microbiol. 2003 May;41(5):1869-74
references.pmid: 12734219
references.citation: Infect Immun. 2013 Dec;81(12):4604-14
references.pmid: 24082077
references.citation: BMC Immunol. 2009 May 08;10:26
references.pmid: 19426498
references.citation: Emerg Infect Dis. 2002 Aug;8(8):833-41
references.pmid: 12141970
references.citation: J Mol Biol. 1992 Mar 20;224(2):487-99
references.pmid: 1560463
references.citation: Infect Immun. 2011 Jan;79(1):512-7
references.pmid: 20956568
references.citation: Infect Immun. 2001 Feb;69(2):1009-15
references.pmid: 11159997
references.citation: Adv Immunol. 2006;91:1-44
references.pmid: 16938537
references.citation: Acta Virol. 1979 Jan;23(1):73-81
references.pmid: 35962
references.citation: Adv Exp Med Biol. 2012;984:231-48
references.pmid: 22711635
references.citation: J Mol Biol. 1994 Jan 14;235(2):625-34
references.pmid: 8289285
references.citation: Microbiol Immunol. 1995;39(9):663-71
references.pmid: 8577279
references.citation: J Gen Virol. 2002 Sep;83(Pt 9):2091-2108
references.pmid: 12185262
references.citation: Adv Exp Med Biol. 2012;984:1-11
references.pmid: 22711624
references.citation: FEMS Immunol Med Microbiol. 2004 Jan 15;40(1):71-4
references.pmid: 14734189
references.citation: QJM. 2002 Aug;95(8):491-2
references.pmid: 12145387
references.citation: Vet Microbiol. 2010 Jan 27;140(3-4):297-309
references.pmid: 19875249
references.citation: Infect Immun. 1982 Mar;35(3):1091-102
references.pmid: 7068212
references.citation: Infect Immun. 2013 Jun;81(6):2112-22
references.pmid: 23545296
references.citation: Clin Microbiol Rev. 1999 Oct;12(4):518-53
references.pmid: 10515901
references.citation: J Immunol. 2012 Nov 15;189(10):4909-20
references.pmid: 23053512
references.citation: Arch Intern Med. 1999 Jan 25;159(2):167-73
references.pmid: 9927100
references.citation: Mayo Clin Proc. 2008 May;83(5):574-9
references.pmid: 18452690
references.citation: Methods Mol Biol. 2004;248:135-59
references.pmid: 14970494
references.citation: Infect Immun. 2006 Feb;74(2):1016-24
references.pmid: 16428748
references.citation: Science. 2001 Oct 5;294(5540):93-6
references.pmid: 11588250
references.citation: J Immunol Methods. 2004 Aug;291(1-2):1-10
references.pmid: 15345300
references.citation: Infect Immun. 2007 Jul;75(7):3245-55
references.pmid: 17438029